{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T04:04:18Z","timestamp":1792728258273,"version":"4.5.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T00:00:00Z","timestamp":1731369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T00:00:00Z","timestamp":1731369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s10096-024-04986-6","type":"journal-article","created":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T14:09:59Z","timestamp":1731420599000},"page":"193-196","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Meropenem-vaborbactam as intrathecal-sparing therapy for the treatment of carbapenem-resistant K. pneumoniae shunt-related ventriculitis: two case reports and review of the literature"],"prefix":"10.1007","volume":"44","author":[{"given":"Gabriele","family":"Giuliano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margherita","family":"Sambo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Castellani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Benedetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Tarantino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Tumbarello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,12]]},"reference":[{"key":"4986_CR1","doi-asserted-by":"publisher","first-page":"697","DOI":"10.2147\/IDR.S326456","volume":"15","author":"M Karvouniaris","year":"2022","unstructured":"Karvouniaris M, Brotis A, Tsiakos K, Palli E, Koulenti D (2022) Current perspectives on the diagnosis and management of Healthcare-Associated Ventriculitis and Meningitis. Infect Drug Resist 15:697\u2013721. https:\/\/doi.org\/10.2147\/IDR.S326456","journal-title":"Infect Drug Resist"},{"key":"4986_CR2","doi-asserted-by":"publisher","first-page":"3807","DOI":"10.2147\/IDR.S416948","volume":"16","author":"C Li","year":"2023","unstructured":"Li C, Zhou P, Liu Y, Zhang L (2023) Treatment of Ventriculitis and Meningitis after Neurosurgery caused by Carbapenem-Resistant Enterobacteriaceae (CRE): a challenging topic. Infect Drug Resist 16:3807\u20133818. https:\/\/doi.org\/10.2147\/IDR.S416948","journal-title":"Infect Drug Resist"},{"issue":"6","key":"4986_CR3","doi-asserted-by":"publisher","first-page":"e34","DOI":"10.1093\/cid\/ciw861","volume":"64","author":"AR Tunkel","year":"2017","unstructured":"Tunkel AR, Hasbun R, Bhimraj A, Byers K, Kaplan SL, Scheld WM et al (2017) Infectious Diseases Society of America\u2019s clinical practice guidelines for Healthcare-Associated Ventriculitis and Meningitis. Clin Infect Dis 64(6):e34\u2013e65. https:\/\/doi.org\/10.1093\/cid\/ciw861","journal-title":"Clin Infect Dis"},{"issue":"1","key":"4986_CR4","doi-asserted-by":"publisher","first-page":"dlac022","DOI":"10.1093\/jacamr\/dlac022","volume":"4","author":"M Tumbarello","year":"2022","unstructured":"Tumbarello M, Raffaelli F, Cascio A, Falcone M, Signorini L, Mussini C et al (2022) Compassionate use of meropenem\/vaborbactam for infections caused by KPC-producing Klebsiella pneumoniae: a multicentre study. JAC Antimicrob Resist 4(1):dlac022. https:\/\/doi.org\/10.1093\/jacamr\/dlac022","journal-title":"JAC Antimicrob Resist"},{"issue":"6","key":"4986_CR5","doi-asserted-by":"publisher","first-page":"ofae273","DOI":"10.1093\/ofid\/ofae273","volume":"11","author":"M Tumbarello","year":"2024","unstructured":"Tumbarello M, Raffaelli F, Giannella M, De Pascale G, Cascio A, De Rosa FG et al (2024) Outcomes and predictors of mortality in patients with KPC-Kp infections treated with Meropenem Vaborbactam: an Observational Multicenter Study. Open Forum Infect Dis 11(6):ofae273. https:\/\/doi.org\/10.1093\/ofid\/ofae273","journal-title":"Open Forum Infect Dis"},{"issue":"9","key":"4986_CR6","doi-asserted-by":"publisher","first-page":"ofaa349","DOI":"10.1093\/ofid\/ofaa349","volume":"7","author":"M Yasmin","year":"2020","unstructured":"Yasmin M, Hanrahan J, Marshall S, Lodise TP, Chen L, Perez F et al (2020) Using Therapeutic Drug Monitoring to treat KPC-Producing Klebsiella pneumoniae central nervous system infection with Ceftazidime\/Avibactam. Open Forum Infect Dis 7(9):ofaa349. https:\/\/doi.org\/10.1093\/ofid\/ofaa349","journal-title":"Open Forum Infect Dis"},{"key":"4986_CR7","doi-asserted-by":"publisher","first-page":"e00963","DOI":"10.1016\/j.idcr.2020.e00963","volume":"22","author":"S Anwar","year":"2020","unstructured":"Anwar S, Acharya S, Thapa S, Rabadi J, Mobarakai N (2020) Carbapenemase producing Klebsiella pneumoniae (KPC) meningitis from chronic otitis media. IDCases 22:e00963. https:\/\/doi.org\/10.1016\/j.idcr.2020.e00963","journal-title":"IDCases"},{"key":"4986_CR8","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.ijid.2022.07.073","volume":"2","author":"S Choi","year":"2022","unstructured":"Choi S, Fedorenko M, Lin-Torre J, Mistry N, Smoke S (2022) A post-neurosurgical infection due to KPC-Producing Klebsiella pneumoniae treated with Meropenem-Vaborbactam: a Case Report. Int J Infect Dis 2:1041\u20131043. https:\/\/doi.org\/10.1016\/j.ijid.2022.07.073","journal-title":"Int J Infect Dis"},{"issue":"5","key":"4986_CR9","doi-asserted-by":"publisher","first-page":"432","DOI":"10.3390\/antibiotics13050432","volume":"13","author":"R Rubino","year":"2024","unstructured":"Rubino R, Trizzino M, Pipit\u00f2 L, Sucato G, Santoro M, Maugeri R et al (2024) A difficult case of Ventriculitis in a 40-Year-old woman with Acute myeloid leukemia. Antibiotics 13(5):432. https:\/\/doi.org\/10.3390\/antibiotics13050432","journal-title":"Antibiotics"},{"key":"4986_CR10","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jgar.2024.03.003","volume":"37","author":"L Volpicelli","year":"2024","unstructured":"Volpicelli L, Cairoli S, Al Ismail D, Baisi F, Sacco F, Goffredo BM et al (2024) Simultaneous post-neurosurgical ventriculitis and bacteraemia by two different strains of KPC-producing K. pneumoniae successfully treated with meropenem\/vaborbactam and high dose of fosfomycin. J Glob Antimicrob Resist 37:86\u201390. https:\/\/doi.org\/10.1016\/j.jgar.2024.03.003","journal-title":"J Glob Antimicrob Resist"},{"issue":"6","key":"4986_CR11","doi-asserted-by":"publisher","first-page":"107177","DOI":"10.1016\/j.ijantimicag.2024.107177","volume":"63","author":"M Gatti","year":"2024","unstructured":"Gatti M, Virgili G, Viale P, Pea F (2024) Is intrathecal or intraventricular therapy with polymyxins or aminoglycosides still needed to improve the outcome of post-neurosurgical extensively\/multidrug-resistant Gram-negative bacteria-related meningitis\/ventriculitis in the current era of novel beta-lactams and beta-lactam\/beta-lactamase inhibitor combinations? Int J Antimicrob Agents 63(6):107177. https:\/\/doi.org\/10.1016\/j.ijantimicag.2024.107177","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"4986_CR12","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.cmi.2015.09.023","volume":"22","author":"B Shofty","year":"2016","unstructured":"Shofty B, Neuberger A, Naffaa ME, Binawi T, Babitch T, Rappaport ZH et al (2016) Intrathecal or intraventricular therapy for post-neurosurgical gram-negative meningitis: matched cohort study. Clin Microbiol Infect 22(1):66\u201370. https:\/\/doi.org\/10.1016\/j.cmi.2015.09.023","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"4986_CR13","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/s10096-024-04794-y","volume":"43","author":"Y Hu","year":"2024","unstructured":"Hu Y, Li D, Zhang G, Dai Y, Chen M, Jiang H et al (2024) Intraventricular or intrathecal polymyxin B for treatment of post-neurosurgical intracranial infection caused by carbapenem-resistant gram-negative bacteria: a 8-year retrospective study. Eur J Clin Microbiol Infect Dis 43(5):875\u2013884. https:\/\/doi.org\/10.1007\/s10096-024-04794-y","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"7","key":"4986_CR14","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1080\/14787210.2020.1754193","volume":"18","author":"KG Tsegka","year":"2020","unstructured":"Tsegka KG, Voulgaris GL, Kyriakidou M, Falagas ME (2020) Intravenous fosfomycin for the treatment of patients with central nervous system infections: evaluation of the published evidence. Expert Rev Anti Infect Ther 18(7):657\u2013668. https:\/\/doi.org\/10.1080\/14787210.2020.1754193","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"4","key":"4986_CR15","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s40121-018-0214-1","volume":"7","author":"RG Wunderink","year":"2018","unstructured":"Wunderink RG, Giamarellos-Bourboulis EJ, Rahav G, Mathers AJ, Bassetti M, Vazquez J et al (2018) Effect and safety of Meropenem-Vaborbactam versus best-available therapy in patients with Carbapenem-Resistant Enterobacteriaceae infections: the TANGO II randomized clinical trial. Infect Dis Ther 7(4):439\u2013455. https:\/\/doi.org\/10.1007\/s40121-018-0214-1","journal-title":"Infect Dis Ther"},{"issue":"4","key":"4986_CR16","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.clinthera.2020.01.021","volume":"42","author":"IH Chen","year":"2020","unstructured":"Chen IH, Martin EK, Nicolau DP, Kuti JL (2020) Assessment of Meropenem and Vaborbactam Room Temperature and Refrigerated Stability in polyvinyl chloride bags and Elastomeric devices. Clin Ther 42(4):606\u2013613. https:\/\/doi.org\/10.1016\/j.clinthera.2020.01.021","journal-title":"Clin Ther"},{"issue":"5","key":"4986_CR17","doi-asserted-by":"publisher","first-page":"106992","DOI":"10.1016\/j.ijantimicag.2023.106992","volume":"62","author":"M Gatti","year":"2023","unstructured":"Gatti M, Rinaldi M, Gaibani P, Siniscalchi A, Tonetti T, Viale P et al (2023) A descriptive pharmacokinetic\/pharmacodynamic analysis of continuous infusion meropenem\/vaborbactam in the treatment of critically ill patients with documented KPC-producing Klebsiella pneumoniae ventilator-associated pneumonia. Int J Antimicrob Agents 62(5):106992. https:\/\/doi.org\/10.1016\/j.ijantimicag.2023.106992","journal-title":"Int J Antimicrob Agents"},{"issue":"6","key":"4986_CR18","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1007\/s15010-023-02055-2","volume":"51","author":"R Larcher","year":"2023","unstructured":"Larcher R, Laffont-Lozes P, Naciri T, Bourgeois PM, Gandon C, Magnan C et al (2023) Continuous infusion of meropenem-vaborbactam for a KPC-3-producing Klebsiella pneumoniae bloodstream infection in a critically ill patient with augmented renal clearance. Infection 51(6):1835\u20131840. https:\/\/doi.org\/10.1007\/s15010-023-02055-2","journal-title":"Infection"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-024-04986-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-024-04986-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-024-04986-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T10:46:12Z","timestamp":1737024372000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-024-04986-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,12]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["4986"],"URL":"https:\/\/doi.org\/10.1007\/s10096-024-04986-6","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,12]]},"assertion":[{"value":"15 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Clinical practices described have been approved by the Regional Ethics Committee for Clinical Trials of the Tuscany Region (Section: Area Vasta Sud-Est) with protocol number 26582.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare that they have no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}